During the Amsterdam Science & Innovation Award, nine scientists will pitch their innovative ideas. Three prizes will be awarded to the best ideas in the categories alpha/ gamma, beta and life sciences.
Get a unique and exclusive opportunity to meet the ideas during the festive finale, register now.
The Innovation Award consists of three prizes of € 7.500. The prizes will be awarded to the most innovative scientific ideas of Amsterdam in the categories Alpha/ Gamma, Beta and Life Sciences. Furthermore, the Impact Award will be awarded to established researchers from Amsterdam who have acquired a track record in the field of valorisation. The impact award honers researchers for their meaningful contribution to society.
The Amsterdam Science & Innovation Award 2019 received a wide variety of ideas. For example, innovations tackle problems within education and try to counter human rights violations or climate change and waste issues. Multiple ideas are devised to solve a variety of challenges by using 3D printing or virtual reality. Apps were developed as well to support medical staff and patients and resolutions were discovered to oppose problems within drugs. In case you want to know more, make sure to register for the finale or download the booklet with the ideas of 2019 after the finale.
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News